Abstract
This disclosure relates to isolated oligonucleotides comprising duplex regions targeting human CFB mRNA, and delivery systems, and compositions comprising the same, and methods of using the same for inhibiting or downregulating CFB gene expression.
Full Text
What is claimed is:
This disclosure relates to isolated oligonucleotides comprising duplex regions targeting human CFB mRNA, and delivery systems, and compositions comprising the same, and methods of using the same for inhibiting or downregulating CFB gene expression.
Timeline
Filed
03/19/2026Published
07/23/2026Granted
Not AvailableIPC Codes(2)
C12N 15/113:Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
A61P 37/06:Immunosuppressants, e.g. drugs for graft rejection